Welcome to LookChem.com Sign In|Join Free

CAS

  • or

197080-73-2

Post Buying Request

197080-73-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

197080-73-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 197080-73-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,7,0,8 and 0 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 197080-73:
(8*1)+(7*9)+(6*7)+(5*0)+(4*8)+(3*0)+(2*7)+(1*3)=162
162 % 10 = 2
So 197080-73-2 is a valid CAS Registry Number.

197080-73-2Relevant articles and documents

A New Lead Identification Strategy: Screening an sp3-rich and Lead-like Compound Library Composed of 7-Azanorbornane Derivatives

Karaki, Fumika,Umemoto, Sho,Ashizawa, Karin,Oki, Tomoya,Sato, Noriko,Ogino, Takumi,Ishibashi, Naoto,Someya, Ryoto,Miyano, Kanako,Hirayama, Shigeto,Uezono, Yasuhito,Fujii, Hideaki

, p. 1840 - 1848 (2019)

Although the advantages of sp3-rich, sterically complicated molecules in drug development have been pointed out, modern screening libraries are filled with planar, sp2-rich components. Compounds that are sp3-rich are difficult to synthesize, and thus we aimed to invent an efficient method to construct sp3-rich libraries. By modifying sp3-rich 7-azanorbornane scaffolds through click chemistry, we efficiently prepared a small set of compounds. These compounds were not only sp3-rich, but also had sufficient “lead-like” properties in view of molecular weights and hydrophobicity. Screening assays of this library provided weak κ opioid receptor agonists and growth hormone secretagogue receptor agonists with high hit rates. These results indicate that the 7-azanorbornane scaffold may be a “privileged structure” for lead identification in drug discovery.

PYRROLOPYRIDINE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF

-

Paragraph 0140; 0141, (2017/11/06)

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of Retinoic Acid Receptor-Related Orphan Receptor regulated diseases and disorders.

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

-

Paragraph 0344, (2015/05/26)

Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 197080-73-2